If you have been reading about Somatotroph and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-03-03. Numbers and descriptions here follow the published literature rather than marketing material.
作用位置在垂体前叶。tesamorelin 与 GHRH 受体结合后激活腺苷酸环化酶，升高细胞内 cAMP，再经蛋白激酶 A 通路促进生长激素的合成与释放。由于它作用于内源调控节点，生长激素仍以脉冲方式分泌，而不是被持续抬升到固定水平。生长激素随后在肝脏等组织诱导胰岛素样生长因子 1 产生，构成完整的生长激素轴响应。
研究背景集中在特定人群的体成分改变，尤其是与脂肪分布异常相关的内脏脂肪堆积。不同地区对它的监管状态与获批适应症并不一致，部分市场仅限特定诊断人群使用。在一般人群中的长期效应、与其他激素的相互作用以及停药后的维持情况仍属开放问题，现有数据不足以给出普遍结论。
Physicochemical behavior is dominated by the peptide backbone. The molecule is hydrophilic and carries a net positive charge near neutral pH, owing to several arginine and lysine residues. In solution it adopts a largely unstructured conformation, and aggregation is a known concern for peptide products of this size. Oxidation of methionine and deamidation of asparagine or glutamine residues are the principal chemical degradation routes. These liabilities shape how the material is formulated, handled, and analyzed, and they explain why lyophilized presentations are common in research settings.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, built from 44 amino acids. Its sequence follows the natural human GHRH(1-44) backbone, with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification blocks recognition by dipeptidyl peptidase IV, the enzyme that rapidly truncates the native hormone in circulation. The result is a molecule with a substantially longer plasma residence time than unmodified GHRH, which makes it practical for clinical and laboratory study.
| 性质 | 取值 | 备注 |
|---|---|---|
| 分子类型 | 合成四十四肽 | GHRH 类似物 |
| N 端修饰 | 反式-3-己烯酰基 | 延缓酶切 |
| 分子量 | 约 5135 Da | 依序列与修饰 |
| 受体靶点 | 垂体 GHRH 受体 | 经 cAMP 通路 |
| 常见同义名 | GHRH(1-44) 类似物 | 文献通用称法 |
After injection, the peptide binds receptors on somatotroph cells in the anterior pituitary. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone into the bloodstream. Because the compound works through the body's own regulatory system, growth hormone pulses retain much of their normal feedback control. Repeated administration also raises insulin-like growth factor 1, a hormone produced mainly in the liver. Investigators treat that rise as a marker that the pituitary axis has been engaged.
Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.
Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.
Development work on the compound, originally designated TH9507, focused on conditions in which reduced growth hormone signaling is thought to contribute to altered body composition. The United States Food and Drug Administration approved it in 2010 for the treatment of excess visceral abdominal fat in adults with human immunodeficiency virus infection and lipodystrophy. Later research examined other populations, including adults with mild cognitive impairment, where a large trial did not meet its primary endpoints. This mixed record illustrates how a single mechanism can produce clear effects in one setting and inconclusive results in another.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a peptide hormone produced by the hypothalamus. The molecule retains the 44-amino-acid sequence of human GHRH and carries a trans-3-hexenoyl modification at its N-terminus. This modification increases resistance to enzymatic degradation and extends the peptide's functional stability relative to native GHRH. The compound is supplied as a lyophilized powder for reconstitution and subcutaneous administration in clinical settings. Its development code was TH9507, and it belongs to the GHRH analog class. It is not a growth hormone product; instead, it acts upstream to stimulate endogenous growth hormone release.
Clinical interest in tesamorelin arose from the need to address visceral adiposity in people living with HIV. Antiretroviral therapy improved survival but was associated in some patients with central fat accumulation, altered lipid profiles, and metabolic complications. This condition, often called HIV-associated lipodystrophy, involves excess visceral adipose tissue that is difficult to manage through diet and exercise alone. Investigators evaluated tesamorelin because GHRH analogs can stimulate growth hormone secretion and influence fat distribution without direct liposuction or invasive procedures.
A Phase 3 program led to regulatory approval in the United States in 2010 for reduction of excess visceral abdominal fat in adults with HIV and lipodystrophy. Subsequent studies examined effects on liver fat, muscle area, and metabolic markers, with mixed findings for some endpoints. Long-term cardiovascular outcomes and effects on mortality remain uncertain because most trials were relatively short and focused on imaging-based fat measurements. Use in populations without HIV has been studied experimentally but is not part of the approved indication.
=== Puerto Rican women === The history of sterilizations in the United States and Puerto Rico can be defined as an intersectional form of oppression that connects race, class, and sex to the social, political, and economic status of Puerto Ricans. The oppressive nature of these procedures lie within the fact that they were politically backed and used within the court of law against Puerto Ricans. Other women on the island experienced an increase in surveillance and control of their body within social realms. This illustrates how sterilizations were conducted on a continuum and had vast as well as long lasting consequences. In 1947, 7% of mothers aged 20–49 received tubal ligation which almost doubled in 1954 as sterilizations increased on the island to 16%. By 1965, over 34% of Puerto Rican women within this age bracket received sterilizations, which is five times the rate two decades prior. Sterilization was the most heavily promoted method of contraception in Puerto Rico and was legitimized by concerns of population, which can be associated with the same concerns of race and class that date back to the island's annexation. After the US gained ownership of Puerto Rico, it was viewed as a province in urgent need of a way to prevent greater poverty and population rates. This heavily influenced the US decision to begin sterilizing Puerto Rican women and implementing experimental birth control methods. Puerto Rican women in particular have served as test subjects for various contraceptive studies in the United States, of which included involuntary sterilization.
Each PLA probes comes with a unique short DNA strand attached to it and bind either to species specific primary antibodies or consist of directly DNA-labeled primary antibodies. When the PLA probes are in close proximity, the DNA strands can interact through a subsequent addition of two other circle-forming DNA oligonucleotides. After joining of the two added oligonucleotides by enzymatic ligation, they are amplified via rolling circle amplification using a polymerase. After the amplification reaction, several-hundredfold replication of the DNA circle has occurred and flurophore or enzyme labeled complementary oligonucleotide probes highlight the product. The resulting high concentration of fluorescence or cromogenic signal in each single-molecule amplification product is easily visible as a distinct bright spot when viewed with either in a fluorescence microscope or a standard brightfield microscope.
All lipids can experience some sort of positive or negative alternating or spontaneous curvature due to variations in sizes between the hydrophobic and the hydrophilic region. Temperature changes can also lead to changes in the biomembrane.
==== 17 April 2012 massacre ==== Dismembered remains of 14 men were found in several plastic bags inside a Chrysler Voyager in the border city of Nuevo Laredo, Tamaulipas, on 17 April 2012. All of those killed were between the ages of 30 and 35. Officials stated that they found a "message signed by a criminal group", but they did not release the content of the note, nor if those killed were members of Los Zetas or of the Gulf Cartel. CNN en Español stated that the message left behind by the criminal group said that they were going to "clean up Nuevo Laredo" by killing Zeta members. The Monitor newspaper, however, said that a source outside of law enforcement but with direct knowledge of the attacks stated the 14 bodies belonged to members of Los Zetas who had been killed by the CJNG, now a branch of the Sinaloa Cartel. Following the attacks, the Sinaloa cartel's kingpin, Joaquín Guzmán Loera—better known as El Chapo Guzmán—sent a message to Los Zetas that they will fight for the control of the Nuevo Laredo plaza. The message read the following:
Birch bark tar use as an adhesive began in the Middle Paleolithic. Neanderthals produced tar through dry distillation of birch bark as early as 200,000 years ago. A 2019 study demonstrated that birch bark tar production can be a simpler, more discoverable process by directly burning birch bark under overhanging stone surfaces in open-air conditions. However, at Königsaue (Germany), Neanderthals did not make tar with this method but rather employed a technically more demanding underground production method. A find from the Dutch North Sea and two tools from the Italian site Campitello show that Neanderthals used birch bark tar as a backing on small 'domestic' stone tools. Birch bark tar also has been used as a disinfectant, in leather dressing, and in medicine. A piece of 5,000-year-old chewing gum made from birch bark tar, and still bearing tooth imprints, was found in Kierikki, Finland. Genetic material left in the gum enabled novel research to identify population movements, types of food consumed, and types of oral bacteria found on their teeth. A different chewing gum sample, dated to 5,700 years old, was found in southern Denmark. A complete human genome and oral microbiome was sequenced from chewed birch bark tar. Researchers identified that the individual who chewed the gum was a female who was closely related genetically to hunter-gatherers from mainland Europe. Fletching on arrows were fastened with birch bark tar, and rawhide lashing and birch bark tar were used to fix axe blades in the Mesolithic period.
Sources: en.wikipedia.org
The most common side effect is eye irritation felt as stinging or burning, which occurs in up to a third of patients. Blepharoconjunctivitis occurs in up to 5% of patients. Rarer adverse effects include keratitis, edema and increased lacrimation. Allergies are rare, but seem to be more common than under the related drug timolol. If the substance reaches the nasal mucosa via the tear duct, it can be absorbed into the bloodstream and cause systemic side effects. These include orthostatic hypotension (low blood pressure) and other effects on the heart and circulatory system, breathing problems in people with asthma, and skin symptoms such as itching and aggravation of psoriasis.
== Biomedical applications == The oldest application is also the simplest: the surgical suture. Braided silk is easy to handle and holds a knot securely, and it remains in clinical use, although it can provoke a tissue reaction and lose strength over time, and synthetic threads have replaced it in some procedures. Porous silk scaffolds serve as temporary frameworks for regrowing tissue. Because their strength can be set and their degradation slowed, they suit tissues that either bear load or heal slowly—bone, cartilage, skin, and connective tissues such as ligament and tendon, where the toughness of silk is an advantage. Cells are seeded onto the scaffold, which provides mechanical support while they become established and is gradually replaced by the body's own tissue. Silk films, gels and particles can hold a drug and release it slowly. The mild, water-based processing is the principal advantage: sensitive drugs and proteins survive incorporation, and release can be slowed by increasing the beta-sheet content of the surrounding silk. Silk coatings have also been used to stabilise vaccines and other biologics against heat. Thin silk films are transparent, can be moulded with fine surface patterns and dissolve in the body, a combination well suited to biodegradable electronics and optics. Silicon components have been fabricated on silk films designed to conform to tissue and then dissolve once their function is complete, an approach known as transient or bioresorbable electronics. Silk has also been formed into lenses, diffraction gratings and sensors.
=== Dry-cleaning === Supercritical carbon dioxide (SCD) can be used instead of PERC (perchloroethylene) or other undesirable solvents for dry-cleaning. Supercritical carbon dioxide sometimes intercalates into buttons, and, when the SCD is depressurized, the buttons pop, or break apart. Detergents that are soluble in carbon dioxide improve the solvating power of the solvent. CO2-based dry cleaning equipment uses liquid CO2, not supercritical CO2, to avoid damage to the buttons.
== Contraindications == Somapacitan should not be used in people with active malignancy, any stage of diabetic eye disease in which high blood sugar levels cause damage to blood vessels in the retina, acute critical illness, or those with acute respiratory failure, because of the increased risk of mortality with use of pharmacologic doses of somapacitan in critically ill individuals without growth hormone deficiency.
Sources: en.wikipedia.org
tesamorelin 属 GHRH 类似物，作用于垂体受体以促进内源生长激素释放；生长激素本身是直接补充的外源激素。两者在给药逻辑、作用位点和反馈调控路径上并不相同。
作为多肽，它难以通过胃肠道吸收，通常需要注射给药。口服会因消化酶降解而失去活性，因此文献中讨论的都是注射途径。
公开研究多集中在内脏脂肪、体成分分布以及与生长激素轴相关的代谢指标。长期安全性和在普通人群中的适用性尚缺乏一致结论。
The principal difference is a chemical cap on the N-terminal tyrosine that prevents rapid enzymatic cleavage. Native GHRH is degraded within minutes in plasma, whereas the modified peptide persists considerably longer. The amino acid backbone otherwise mirrors the natural hormone.